CSPC Pharmaceutical Group Limited (CVG) — Cash Flow Quality Index
CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Quality Index of 1.79x as of September 2020. Operating cash flow of €2.16 Billion exceeds net income of €1.20 Billion, indicating high earnings quality where cash backs reported profits. Explore CVG operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC Pharmaceutical Group Limited Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for CSPC Pharmaceutical Group Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of CSPC Pharmaceutical Group Limited.
Annual Cash Flow Quality Index for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year earnings quality comparison for CSPC Pharmaceutical Group Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | ▼ -38.6% |
| 2020 | 1.09x | €6.74 Billion | €6.16 Billion | ▲ +7.4% |
| 2019 | 1.02x | €3.78 Billion | €3.71 Billion | ▼ -17.3% |
| 2018 | 1.23x | €3.80 Billion | €3.08 Billion | ▲ +3.8% |
| 2017 | 1.19x | €3.29 Billion | €2.77 Billion | ▼ -23.4% |
| 2016 | 1.55x | €2.92 Billion | €1.88 Billion | ▲ +14.8% |
| 2015 | 1.35x | €2.25 Billion | €1.67 Billion | ▼ -5.2% |
| 2014 | 1.42x | €1.81 Billion | €1.27 Billion | ▲ +70.0% |
| 2013 | 0.84x | €814.86 Million | €972.75 Million | — |